BioRestorative Therapies Company Profile (NASDAQ:BRTX)

Analyst Ratings

Consensus Ratings for BioRestorative Therapies (NASDAQ:BRTX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for BioRestorative Therapies (NASDAQ:BRTX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for BioRestorative Therapies (NASDAQ:BRTX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for BioRestorative Therapies (NASDAQ:BRTX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for BioRestorative Therapies (NASDAQ:BRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioRestorative Therapies (NASDAQ:BRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/18/2016Robert B CatellDirectorBuy12,500$4.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016John M DesmaraisDirectorBuy250,000$4.00$1,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016Robert B CatellDirectorBuy37,500$4.00$150,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioRestorative Therapies (NASDAQ:BRTX)
DateHeadline
07/15/16 01:33 PMBioRestorative Therapies : Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
07/13/16 09:47 AMBioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course - [GlobeNewswire] - MELVILLE, N.Y., July 13, 2016-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced that Ed Field, the Company’ s President of the Disc/Spine Division, ...
06/30/16 03:36 PMBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under a -
06/28/16 03:08 PMData Collected Showed No Adverse Events
06/28/16 08:45 AMBioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain - [GlobeNewswire] - MELVILLE, N.Y., June 28, 2016-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced the completion of a human study entitled“ Re-consenting and ...
06/02/16 05:02 AMBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
05/31/16 08:45 AMBioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference - [GlobeNewswire] - MELVILLE, N.Y., May 31, 2016-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced that Mark Weinreb, the Company’ s CEO, will present a Company ...
05/24/16 03:57 PMBioRestorative Therapies : Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders - (GlobeNewswire) - BioRestorative Therapies, Inc. ("BRT" or "the Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that promising data has been developed on the transplantation of human stem cell-derived ...
05/23/16 08:45 AMBioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders - [GlobeNewswire] - MELVILLE, N.Y., May 23, 2016-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced that promising data has been developed on the transplantation ...
05/13/16 04:39 PMBIORESTORATIVE THERAPIES, INC. Files SEC form 10-Q, Quarterly Report -
03/30/16 04:35 PMBIORESTORATIVE THERAPIES, INC. Files SEC form 10-K, Annual Report -
03/24/16 10:55 AMBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E -
02/24/16 12:53 PMBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial -
12/28/15 10:22 AMBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Change in Dir -
12/21/15 07:00 AMBioRestorative Therapies Provides Company Updates With Shareholder Letter - [GlobeNewswire] - MELVILLE, N.Y., Dec. 21, 2015-- BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, today announced the issuance of a shareholder letter by Chief Executive Officer, ...
12/08/15 12:18 PMBIORESTORATIVE THERAPIES, INC. Financials -
04/14/15 06:45 AMBioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York - [Business Wire] - BioRestorative Therapies, Inc. , a life sciences company focused on adult stem cell-based therapies for various personal medical applications,
04/08/15 07:52 AMBioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors - [Business Wire] - BioRestorative Therapies, Inc. , a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, today announced the appointment of Charles S.

Social

About BioRestorative Therapies

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The Company offers human and plant stem cell derived cosmetic and skin care products. Its programs relate to the treatment of disc/spine disease and metabolic disorders and include Disc/Spine Program (brtxDISC) and Metabolic Program (ThermoStem). Its curved needle device (CND) is a needle system with a curved inner cannula to allow access to difficult-to-locate regions for the delivery or removal of fluids and other substances. The CND is intended to deliver stem cells and/or other therapeutic products or material to the interior of a human intervertebral disc, the spine region, or other areas of the body. The device relies on the use of pre-curved nested cannulae that allows the cells or material to be deposited in the posterior and lateral aspects of the disc to which direct access is not possible due to outlying structures.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BRTX
  • CUSIP:
Key Metrics:
  • Previous Close: $3.40
  • 50 Day Moving Average: $3.65
  • 200 Day Moving Average: $3.85
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $13.42M
  • Current Year EPS Consensus Estimate: $N/A EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links:
BioRestorative Therapies (NASDAQ:BRTX) Chart for Sunday, July, 24, 2016